Should African Americans have a lower blood pressure goal than other ethnic groups to prevent organ damage?

Current Cardiology Reports

Volumn 14, Issue 6, 2012, Pages 660-666

  Flack, John M ^a   Okwuosa, Tochukwi ^a   Sudhakar, Rajeev ^a   Ference, Brian ^a   Levy, Phillip ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

African Americans; Cardiovascular disease; Hypertension; Hypertension control rates; Target blood pressure; Target organ injury

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; CAUCASIAN; DRUG EFFICACY; ETHNIC DIFFERENCE; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; NEGRO; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; TREATMENT RESPONSE;

AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PATIENT CARE PLANNING; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; STROKE;

EID: 84870571629     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-012-0314-6     Document Type: Article

References (29)

1. Prospective Studies Collaboration. Age-specific relevance of usual pressure to vascular mortality: a meta-analysis of individual data for 1 million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
2. Law MR. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiologic studies. BMJ. 2009;338:1-19.
3. Flack JM, Gardin JM, Yunis C, Liu K. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the CARDIA study. Am Heart J. 1999;138(5 Pt 1):856-64.
4. Hefferman KS, Jae SY, Wilund KR, et al. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295:H2380-7.
5. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;xx:xxxx.
6. Drazner MH, Dries DL, Peshock RM, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005;46:124-9.
7. Dyer AR, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens. 1999;13:13-21.
8. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. Population in 1988-2006. Diabetes Care. 2010;33:562-8.
9. Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273:1592-7.
10. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
11. Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993;21(Suppl):31-40.
12. Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-41.
13. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360:1179-90.
14. Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649-56.
15. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;12(317):703-13.
16. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497-502.
17. Centers for Disease Control. Compressed mortality file: underlying cause-of-death. National Center for Health Statistics. 2008. Available at: http://wonder.cdc.gov/mortSQL.html.
18. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks Consensus Statement. Hypertension. 2010;56:780-800.
19. Wright Jr JT, Agodoa LY, Appel L, et al. New recommendations for treating hypertension in black patients: evidence and/or consensus? Hypertension. 2010;56:801-3.
20. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.
21. Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614-27.
22. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;302:831-41.
23. Weir MR, Bakris GL, Weber MA, et al. Renal outcomes in hypertensive Black patients at high cardiovascular risk. Kidney Int. 2012;81:568-76.
24. Neaton JD, Grimm Jr RH, Prineas RJ, et al. Treatment of mild hypertension study: final results. JAMA. 1993;270:713-24.
25. Verdecchia P, Staessen JA, Angeli F, et al. Usual vs tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomized trial. Lancet. 2009;374:525-33.
26. Lopes AA, Andrade J, Noblat AC, Silveira MA. Reduction in diastolic blood pressure and cardiovascular mortality in nondiabetic hypertensive patients. A reanalysis of the HOT study. Arg Bras Cardiol. 2001;77:132-7.
27. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy, and strokes. Kidney Int. 2002;61:1086-97.
28. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(Suppl):B54-64.
29. ACCORD Study Group. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-85.